VITREOMACULAR TRACTION AFTER DEXAMETHASONE INTRAVITREAL IMPLANT (OZURDEX) INJECTION: THE EFFECT OF ANOMALOUS POSTERIOR VITREOUS DETACHMENT. Issue Volume 10:Issues 1(2016:Winter) (2016)

• Record Type: Journal Article
• Authors: Panjaphongse, Ronakorn; Stewart, Jay M.
• Is Part Of: Retinal cases & brief reports. Volume 10:Issues 1(2016:Winter)
• Publication Date: 2016
• Subjects: dexamethasone intravitreal implant -- diabetic retinopathy -- Ozurdex -- vitreomacular traction -- vitreoschisis; Retina -- Diseases -- Periodicals; Retina -- Periodicals; Retinal Diseases -- Periodicals; Retina -- Case Reports; Retinal Diseases -- Case Reports; 617.7
• DOI: 10.1097/ICB.0000000000000172
• Languages: English
• ISSNs: 1935-1089

Abstract

Abstract : Purpose: To describe an unusual macular complication after dexamethasone intravitreal implant (Ozurdex) injection. Methods: Case history and macular optical coherence tomography findings are described. The report describes a patient with proliferative diabetic retinopathy and vitreoschisis who received Ozurdex treatment for diabetic macular edema. Results: After Ozurdex injection, visual acuity worsened because of newly formed vitreomacular traction that was demonstrated on optical coherence tomography imaging. A mechanism is proposed by which the medication might have contributed to this outcome. Conclusion: In this patient with vitreoschisis, a thickened posterior hyaloid membrane and traction developed after Ozurdex injection. The authors recommend careful evaluation of the macula before injection, particularly in diabetic patients with vitreoschisis. Abstract : Vitreomacular traction developed in a patient with proliferative diabetic retinopathy after Ozurdex injection. This was due to thickening and contraction of the posterior hyaloid in the setting of vitreoschisis.